These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9648714)

  • 41. [Guillain-Barré syndrome in children treated with intravenous immunoglobulin].
    Andersen UM
    Ugeskr Laeger; 1993 Oct; 155(42):3392-4. PubMed ID: 8259633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum IgG subclass concentrations before and after administration of intravenous immunoglobulin in common variable immunodeficiency.
    Ozawa T; Motoyoshi F; Kato Y; Kondo N; Orii T
    J Clin Lab Immunol; 1992; 38(1):29-39. PubMed ID: 1343346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunologic thrombopenic purpura in children: therapeutic trial with high dose of intravenous gamma globulins].
    Portas M; Armengaud D; Auffeuvre JP; Barois A; Gallet JP; Leroy B; Magloire C; Blancher G
    Ann Med Interne (Paris); 1985; 136(1):13-6. PubMed ID: 2408530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful treatment of cutaneous lesions in juvenile dermatomyositis with high-dose intravenous immunoglobulin.
    Amano H; Nagai Y; Katada K; Hashimoto C; Ishikawa O
    Br J Dermatol; 2007 Jun; 156(6):1390-2. PubMed ID: 17459039
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment with human gamma globulin].
    Matamoros Florí N
    Med Clin (Barc); 1995 Feb; 104(6):216-7. PubMed ID: 7534368
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of toxic epidermal necrolysis (TEN) with low dose intravenous immunoglobulin in child.
    Habib A; Pasha W; Raza N
    J Coll Physicians Surg Pak; 2010 Mar; 20(3):205-7. PubMed ID: 20392387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both.
    Gereige RS; Barrios NJ
    P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prospective controlled crossover trial of a new presentation (10% vs. 5%) of a heat-treated intravenous immunoglobulin.
    Matamoros N; De Gracia J; Hernández F; Pons J; Alvarez A; Jiménez V
    Int Immunopharmacol; 2005 Mar; 5(3):619-26. PubMed ID: 15683857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cryoglobulinemia in lepromatous leprosy: an immune complex phenomenon.
    Bonomo L; Dammacco F; Meneghini C; LoSpalluto M
    Int J Lepr Other Mycobact Dis; 1971; 39(2):554-5. PubMed ID: 4260183
    [No Abstract]   [Full Text] [Related]  

  • 50. [Gamma globulins in clinical practice].
    Panizon F
    Pediatr Med Chir; 1993; 15(4):333-5. PubMed ID: 7505432
    [No Abstract]   [Full Text] [Related]  

  • 51. Weekly long-term intravenous immunoglobulin for refractory parvovirus B19 and Epstein-Barr virus-induced immune thrombocytopenic purpura.
    Tavil B; Unal S; Aytaç-Elmas S; Yetgin S
    Turk J Pediatr; 2008; 50(1):74-7. PubMed ID: 18365597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tolerability of subcutaneous immunoglobulin 20%, Ig20Gly, in pediatric patients with primary immunodeficiencies.
    Paris K; Haddad E; Borte M; Brodszki N; Dérfalvi B; Maródi L; Hussain I; Darter A; Engl W; Leibl H; McCoy B; Yel L
    Immunotherapy; 2019 Apr; 11(5):397-406. PubMed ID: 30626238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Acute immune epiduritis in a child].
    Boumpoutou R; Beze-Beyrie P; Guerin B; Couleru G; Bersani D; Doireau V
    Arch Pediatr; 2003 Jun; 10(6):521-3. PubMed ID: 12915015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunoglobulins: Benefits and risks from the patient's point of view.
    Revol B; Bickert L; Sarrot-Reynauld F; Allenet B
    Therapie; 2017 Dec; 72(6):683-684. PubMed ID: 28941580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Biochemical markers of toxic and mutagenic complications of cytostatic pharmacotherapy].
    Serhieieva LA; Chelpan LL; Maĭlian EA; Kurbatov VV
    Lik Sprava; 2002; (2):88-92. PubMed ID: 12073272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous immunoglobulin for Alzheimer's disease.
    Holmes C
    Lancet Neurol; 2013 Mar; 12(3):218-9. PubMed ID: 23375966
    [No Abstract]   [Full Text] [Related]  

  • 57. [111th Scientific Meeting of the Japanese Society of Internal Medicine: Panel Discussion: Internal medicine creating future health care; 1. A new era for treatment of intractable immune disorders].
    Kishimoto T
    Nihon Naika Gakkai Zasshi; 2014 Sep; 103(9):2199. PubMed ID: 27522777
    [No Abstract]   [Full Text] [Related]  

  • 58. Intravenous versus subcutaneous immunoglobulin - Authors' reply.
    van Schaik IN; Mielke O;
    Lancet Neurol; 2018 May; 17(5):393-394. PubMed ID: 29656738
    [No Abstract]   [Full Text] [Related]  

  • 59. Kinase inhibitors in clinical practice: An expanding world.
    Pandey R; Kapur R
    J Allergy Clin Immunol; 2018 Feb; 141(2):522-524. PubMed ID: 28801197
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunoglobulin for intravenous use.
    Foster PR; Welch AG; Cuthbertson B; Perry RJ; McIntosh RV
    Transfus Med; 1997 Mar; 7(1):67-9. PubMed ID: 9089990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.